Listed on the Mainboard of the Singapore Exchange since 2004, Mr. Teh Wing Kwan (“Teh”) was appointed as Executive Chairman and Chief Executive Officer of the Company in July 2018 after he acquired 28.73% equity interest to become the single largest shareholder of the Company. Teh’s key role was to initiate corporate strategic reviews, set new business directions, lead in the implementation of growth initiatives and execute new investment strategies for the Company. Following completion of the Reverse Takeover of Livingstone Health Ltd (the “RTO”), a key corporate turnaround plan for the Company. Teh has been re-designated as Non-Independent and Non-Executive Chairman of the Company. Mr. Fong Heng Boo and Mr. Chan Yu Meng, who have been the appointed Board of Directors, remain as Independent Directors of the Company after the RTO.
For further details, click here to download the Circular to Shareholders.